dark urine semaglutide and UTI: does GLP-1 therapy increase urinary tract infection risk? Ozempic: Semaglutide is a GLP-1

Abstract Objectives: Semaglutide is a glucagon-like peptide 1 receptor agonist that improves glycemic control and achieves weight loss in type 2 diabetes (T2D) patients

Contraindications Is it safe to take it with other drugs

Funding The author(s) declared that financial support was not received for this work and/or its publication

All subjects provided written informed consent before initiation of any trial-related activities

108,109 Mechanisms of microglial activation Several genetically distinct subtypes of microglia have been discovered as they respond to signals or challenges in the brain microenvironment, namely homeostatic microglia and disease-associated microglia (DAM) or microglial neurodegenerative phenotype (MGnD)

The FDA has issued specific guidance on compounded semaglutide, noting that compounded versions are not FDA-approved and have not undergone the same safety and efficacy testing as Novo Nordisk's Ozempic or Wegovy [12]